PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

• Main Authors: Stephen eOrena (Author), Tristan eMaurer (Author), Rena eEudy (Author), Li eShe (Author), Darla eDash (Author), Paula eLoria (Author), Mary Ellen eBanker (Author), Vincent eBernardo (Author), Meera eTugnait (Author), Carlin eOkerberg (Author), Jessie eQian (Author), Carine M Boustany-Kari (Author)
• Format: Book
• Published: Frontiers Media S.A., 2013-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The mineralocorticoid receptor (MR) antagonists PF 03882845 and eplerenone were evaluated for renal protection against aldosterone mediated renal disease in uninephrectomized Sprague Dawley (SD) rats maintained on a high salt diet and receiving aldosterone by osmotic mini pump for 27 days. Serum K+...